Can the incidence of voluntarily reported side effects support the argument for a clinically relevant GLP-1RA tachyphylaxis? Comment on Br J Anaesth 2025; 134:1486-1496. | Pepdox
Can the incidence of voluntarily reported side effects support the argument for a clinically relevant GLP-1RA tachyphylaxis? Comment on Br J Anaesth 2025; 134:1486-1496.